Last Updated

17 Feb 2015

Low-dose Primaquine study

Objectives

Determining a safe and maximally efficacious dosing range of primaquine in combination with standard weight-based dosing of Dihydroartemisinin-piperaquine against Plasmodium falciparum gametocytes in G6PD normal and deficient patients with uncomplicated malaria

Principal Investigator
Funding Information
Supported through core funding from BMGF and from CDC

Date

2014 Jan - 2015 Dec
Project Site